GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Retained Earnings

Biolife Sciences (Biolife Sciences) Retained Earnings : $-5.17 Mil (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Biolife Sciences's retained earnings for the quarter that ended in May. 2008 was $-5.17 Mil.

Biolife Sciences's quarterly retained earnings declined from Nov. 2007 ($-3.89 Mil) to Feb. 2008 ($-4.33 Mil) and declined from Feb. 2008 ($-4.33 Mil) to May. 2008 ($-5.17 Mil).

Biolife Sciences's annual retained earnings declined from Nov. 2005 ($-1.55 Mil) to Nov. 2006 ($-1.84 Mil) and declined from Nov. 2006 ($-1.84 Mil) to Nov. 2007 ($-3.89 Mil).


Biolife Sciences Retained Earnings Historical Data

The historical data trend for Biolife Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Retained Earnings Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Retained Earnings
-0.04 -1.55 -1.84 -3.89

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 -2.86 -3.89 -4.33 -5.17

Biolife Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Biolife Sciences  (OTCPK:BLFE) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020